Table 1 Demographic and comorbidity comparison of kidney transplant recipients with and without hepatitis C virus infection before and after propensity score matching.
Demographics | Before propensity score matching | After propensity score matching | ||||||
|---|---|---|---|---|---|---|---|---|
HCV | Non-HCV | HCV | Non-HCV | |||||
N (%) | N (%) | p-value | Std diff. | N (%) | N (%) | p-value | Std diff. | |
Age | ||||||||
18–40 years | 344(5.30%) | 33150(18.54%) | < 0.0001 | 0.4172 | 344(5.31%) | 358(5.53%) | 0.5869 | 0.0096 |
40–65 years | 4399(67.81%) | 99991(55.92%) | < 0.0001 | 0.2468 | 4390(67.82%) | 4391(67.84%) | 0.985 | 0.0003 |
65 + years | 1741(26.84%) | 41721(23.33%) | < 0.0001 | 0.081 | 1736(26.82%) | 1721(26.59%) | 0.7657 | 0.0052 |
Sex | ||||||||
Male | 4434(68.35%) | 100450(56.17%) | < 0.0001 | 0.2533 | 4425(68.36%) | 4423(68.33%) | 0.9699 | 0.0007 |
Female | 1803(27.79%) | 72618(40.61%) | < 0.0001 | 0.2726 | 1801(27.82%) | 1797(27.76%) | 0.9374 | 0.0014 |
Race | ||||||||
Hispanic or Latino | 741(11.42%) | 19084(10.67%) | 0.0546 | 0.024 | 741(11.45%) | 715(11.05%) | 0.4695 | 0.0127 |
Not Hispanic or Latino | 4251(65.53%) | 116372(65.08%) | 0.4496 | 0.0096 | 4243(65.55%) | 4288(66.24%) | 0.4041 | 0.0147 |
White | 2885(44.47%) | 92111(51.51%) | < 0.0001 | 0.1412 | 2880(44.49%) | 2842(43.91%) | 0.5013 | 0.0118 |
Black or African American | 1972(30.40%) | 38757(21.67%) | < 0.0001 | 0.1998 | 1968(30.40%) | 1997(30.85%) | 0.5803 | 0.0097 |
Asian | 243(3.75%) | 8870(4.96%) | < 0.0001 | 0.0595 | 243(3.75%) | 250(3.86%) | 0.7479 | 0.0057 |
Comorbidities | ||||||||
Hypertensive diseases | 5277(81.35%) | 85062(47.57%) | < 0.0001 | 0.7543 | 5263(81.31%) | 5346(82.59%) | 0.0579 | 0.0333 |
Type 2 diabetes mellitus | 3245(50.02%) | 42072(23.53%) | < 0.0001 | 0.5715 | 3236(49.99%) | 3249(50.19%) | 0.8192 | 0.004 |
Overweight and obesity | 1384(21.34%) | 19976(11.17%) | < 0.0001 | 0.2782 | 1377(21.27%) | 1355(20.93%) | 0.6356 | 0.0083 |
Heart failure | 1422(21.92%) | 16996(9.50%) | < 0.0001 | 0.3463 | 1420(21.94%) | 1445(22.32%) | 0.5966 | 0.0093 |
Glomerular diseases | 900(13.87%) | 18171(10.16%) | < 0.0001 | 0.1144 | 899(13.89%) | 899(13.89%) | 1 | < 0.0001 |
Viral hepatitis B | 436(6.72%) | 936(0.52%) | < 0.0001 | 0.3364 | 422(6.52%) | 378(5.84%) | 0.1083 | 0.0282 |
Glucocorticoids | 3921(60.44%) | 63090(35.28%) | < 0.0001 | 0.5205 | 3907(60.36%) | 3948(60.99%) | 0.4607 | 0.013 |
Tacrolimus | 2721(41.95%) | 34521(19.30%) | < 0.0001 | 0.5067 | 2707(41.82%) | 2709(41.85%) | 0.9716 | 0.0006 |
Mycophenolate mofetil | 2232(34.41%) | 27279(15.25%) | < 0.0001 | 0.4546 | 2220(34.30%) | 2204(34.05%) | 0.7669 | 0.0052 |
Mycophenolic acid | 897(13.83%) | 17364(9.71%) | < 0.0001 | 0.128 | 895(13.83%) | 916(14.15%) | 0.5947 | 0.0094 |
Basiliximab | 559(8.62%) | 4548(2.54%) | < 0.0001 | 0.267 | 555(8.57%) | 551(8.51%) | 0.8999 | 0.0022 |
